Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-09-11
1994-01-11
Raymond, Richard L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
546270, 5483117, 548463, 549363, C07D40512, C07D40712
Patent
active
052783200
ABSTRACT:
Compounds of Structural Formula (I) ##STR1## are produced by chemical modification of directed biosynthesis products. These compounds are squalene synthetase inhibitors and thus useful as cholesterol lowering agents, antifungal agents and cancer treatment agents.
REFERENCES:
patent: 5053425 (1991-10-01), Bartizal et al.
patent: 5096923 (1992-03-01), Bergstrom et al.
Kobel and Traber, European Journal App. Microbiol. Biotechnol. 14: 237-240 (1982).
Hensens et al., J. Antibiotics, 45: 133-135 (1992).
Dolan Catherine A.
Matukaitis Paul D.
Merck & Co. , Inc.
Raymond Richard L.
Winokur Melvin
LandOfFree
Cholesterol lowering compounds produced by directed biosynthesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cholesterol lowering compounds produced by directed biosynthesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholesterol lowering compounds produced by directed biosynthesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1632671